PROTEOMICS - Clinical Applications

Reviews

EarlyView | 2011 | 2010 | 2009 | 2008 | 2007

EarlyView | 2011 | 2010 | 2009 | 2008 | 2007

EarlyView | 2010 | 2009 | 2008 | 2007

EarlyView | 2010 | 2009 | 2008 | 2007

• Ulrike Korf, Christian Löbke, Özgür Sahin, Florian Haller, Holger Sültmann, Dorit Arlt, Annemarie Poustka
  Reverse-phase protein arrays for application-orientated cancer research [Review]
  Prot. Clin. Appl. 2009, 3, No. 10, 1140-1150.

• ---

• Praveen Govender, Michael J. Dunn, Seamas C. Donnelly
  Proteomics and the lung: Analysis of bronchoalveolar lavage fluid [Review]
  Prot. Clin. Appl. 2009, 3, No. 09, 1044-1051.

• ---

• Bruce A. Julian, Hitoshi Suzuki, Yusuke Suzuki, Yasuhiko Tomino, Goce Spasovski, Jan Novak
  Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease [Review]
  Prot. Clin. Appl. 2009, 3, No. 09, 1029-1043.

• ---

• Hermann Lage
  Proteomic approaches for investigation of therapy resistance in cancer [Review]
  Prot. Clin. Appl. 2009, 3, No. 08, 883-911.

• ---

• Juan Madoz-Gúrpide
  Targeting sarcomas by proteomic approaches [Review]
  Prot. Clin. Appl. 2009, 3, No. 07, 758-773.

• ---

• Patrizia Bottoni, Bruno Giardina, Roberto Scatena
  Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications [Review]
  Prot. Clin. Appl. 2009, 3, No. 06, 636-653.

• ---

• Li-Na Wei
  Post-translational modifications of orphan nuclear receptor TR2 – new insights into drug targets for stem cell therapy and the effect of retinoic acid [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 279-285.

• ---

• Sílvia Barceló-Batllori, Ramon Gomis
  Proteomics in obesity research [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 263-278.

• ---

• Andrea Scaloni, Erika Codarin, Vittorio Di Maso, Simona Arena, Giovanni Renzone, Claudio Tiribelli, Franco Quadrifoglio, Gianluca Tell
  Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigations [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 242-262.

• ---

• Emilio Camafeita, José Ramón Lamas, Enrique Calvo, Juan Antonio López, Benjamín Fernández-Gutiérrez
  Proteomics: New insights into rheumatic diseases [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 226-241.

• ---

• Chary López-Pedrera, Nuria Barbarroja, Jose Manuel Villalba
  Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: Genomics and proteomics approaches [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 213-225.

• ---

• Caroline A. Evans, Adam Glen, Colby L. Eaton, Stéphane Larré, James W. F. Catto, Freddie C. Hamdy, Phillip C. Wright, Ishtiaq Rehman
  Prostate cancer proteomics: The urgent need for clinically validated biomarkers [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 197-212.

• ---

• Jing-Jing Li, Robert Z. Qi, Gary Kar Ho Ng, Dong Xie
  Proteomics in gastric cancer research: Benefits and challenges [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 185-196.

• ---

• Blanca Lumbreras, Miquel Porta, Soledad Marquez, Marina Pollán, Lucy A. Parker, Ildefonso Hernández-Aguado
  Sources of error and its control in studies on the diagnostic accuracy of “-omics” technologies [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 173-184.

• ---

• Deborah Penque
  Two-dimensional gel electrophoresis and mass spectrometry for biomarker discovery [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 155-172.

• ---

• Shen Hu, David T. Wong
  Lectin microarray [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 148-154.

• ---

• Robert J. Caiazzo, Jr. Andrew J. Maher, Michael P. Drummond, Corey I. Lander, Oliver W. Tassinari, Bryce P. Nelson, Brian C.-S. Liu
  Protein microarrays as an application for disease biomarkers [Review]
  Prot. Clin. Appl. 2009, 3, No. 02, 138-147.

• ---

• Juan Antonio Vizcaíno, Michael Mueller, Henning Hermjakob, Lennart Martens
  Charting online OMICS resources: A navigational chart for clinical researchers [Review]
  Prot. Clin. Appl. 2009, 3, No. 01, 18-29.

• ---

• Magnus Palmblad, Ali Tiss, Rainer Cramer
  Mass spectrometry in clinical proteomics – from the present to the future [Review]
  Prot. Clin. Appl. 2009, 3, No. 01, 6-17.

• ---

EarlyView | 2010 | 2009 | 2008 | 2007

• Annalisa Vilasi, Pedro R. Cutillas, Robert J. Unwin
  Application of proteomic techniques to the study of urine and renal tissue
  Prot. Clin. Appl. 2008, 2, No. 12, 1564-1574.

• ---

• W. Michael Caudle, Sheng Pan, Min Shi, Thomas Quinn, Jake Hoekstra, Richard P. Beyer, Thomas J. Montine, Jing Zhang
  Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1484-1497.

• ---

• Firas H. Kobeissy, Shankar Sadasivan, Monika W. Oli, Gillian Robinson, Stephen F. Larner, Zhiqun Zhang, Ronald L. Hayes, Kevin K. W. Wang
  Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1467-1483.

• ---

• Stephen M. Hewitt, Mikiko Takikita, Behnoush Abedi-Ardekani, Ylaya Kris, Kathryn Bexfield, Till Braunschweig, Joon-Yong Chung
  Validation of proteomic-based discovery with tissue microarrays
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1460-1466.

• ---

• Niroshan Ramachandran, Sanjeeva Srivastava, Joshua LaBaer
  Applications of protein microarrays for biomarker discovery
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1444-1459.

• ---

• Erin H. Seeley, Richard M. Caprioli
  Imaging mass spectrometry: Towards clinical diagnostics
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1435-1443.

• ---

• Johannes A. Hewel, Andrew Emili
  High-resolution biomarker discovery: Moving from large-scale proteome profiling to quantitative validation of lead candidates
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1422-1434.

• ---

• Visith Thongboonkerd
  Biomarker discovery in glomerular diseases using urinary proteomics
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1413-1421.

• ---

• Xia Xu, Timothy D. Veenstra
  Analysis of biofluids for biomarker research
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1403-1412.

• ---

• Amanda G. Paulovich, Jeffrey R. Whiteaker, Andrew N. Hoofnagle, Pei Wang
  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1386-1402.

• ---

• Gordon Whiteley
  Bringing diagnostic technologies to the clinical laboratory: Rigor, regulation, and reality
  Prot. Clin. Appl. 2008, 2, No. 10-11, 1378-1385.

• ---

• Sulma I. Mohammed, Munazzah Rahman
  Proteomics and genomics of urinary bladder cancer
  Prot. Clin. Appl. 2008, 2, No. 09, 1194-1207.

• ---

• Kasper Rossing, Harald Mischak, Peter Rossing, Joost P. Schanstra, Alex Wiseman, David M. Maahs
  The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy
  Prot. Clin. Appl. 2008, 2, No. 07-8, 997-1007.

• ---

• Lin-Li Lv, Bi-Cheng Liu
  Clinical application of antibody microarray in chronic kidney disease: How far to go?
  Prot. Clin. Appl. 2008, 2, No. 07-8, 989-996.

• ---

• Pavel Gromov, José M. A. Moreira, Irina Gromova, Julio E. Celis
  Proteomic strategies in bladder cancer: From tissue to fluid and back
  Prot. Clin. Appl. 2008, 2, No. 07-8, 974-988.

• ---

• Joshua J. Coon, Petra Zürbig, Mohammed Dakna, Anna F. Dominiczak, Stéphane Decramer, Danilo Fliser, Moritz Frommberger, Igor Golovko, David M. Good, Stefan Herget-Rosenthal, Joachim Jankowski, Bruce A. Julian, Markus Kellmann, Walter Kolch, Ziad Massy, Jan Novak, Kasper Rossing, Joost P. Schanstra, Eric Schiffer, Dan Theodorescu, Raymond Vanholder, Eva M. Weissinger, Harald Mischak, Philippe Schmitt-Kopplin
  CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
  Prot. Clin. Appl. 2008, 2, No. 07-8, 964-973.

• ---

• Giovanni Candiano, Maurizio Bruschi, Andrea Petretto, Laura Santucci, Piero Del Boccio, Andrea Urbani, Elisabetta Bertoni, Rosanna Gusmano, Maurizio Salvadori, Francesco Scolari, Gian Marco Ghiggeri
  Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms
  Prot. Clin. Appl. 2008, 2, No. 07-8, 956-963.

• ---

• Glen L. Hortin, Denis Sviridov
  Analysis of molecular forms of albumin in urine
  Prot. Clin. Appl. 2008, 2, No. 07-8, 950-955.

• ---

• Rebekah L. Gundry, Kenneth R. Boheler, Jennifer E. Van Eyk, Bernd Wollscheid
  A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface
  Prot. Clin. Appl. 2008, 2, No. 06, 892-903.

• ---

• Giordano Pula, Sue Perera, Marianna Prokopi, Anissa Sidibe, Chantal M. Boulanger, Manuel Mayr
  Proteomic analysis of secretory proteins and vesicles in vascular research
  Prot. Clin. Appl. 2008, 2, No. 06, 882-891.

• ---

• Melanie Y. White, Alistair V. G. Edwards, Stuart J. Cordwell, Jennifer E. Van Eyk
  Mitochondria: A mirror into cellular dysfunction in heart disease
  Prot. Clin. Appl. 2008, 2, No. 06, 845-861.

• ---

• W. Robb MacLellan, Yibin Wang, Thomas M. Vondriska, James N. Weiss, Peipei Ping
  Proteomic insights into cardiac cell death and survival
  Prot. Clin. Appl. 2008, 2, No. 06, 837-844.

• ---

• Rebecca L. Charles, Philip Eaton
  Redox signalling in cardiovascular disease
  Prot. Clin. Appl. 2008, 2, No. 06, 823-836.

• ---

• Axel Gödecke, Jürgen Schrader, Michael Reinartz
  Nitric oxide-mediated protein modification in cardiovascular physiology and pathology
  Prot. Clin. Appl. 2008, 2, No. 06, 811-822.

• ---

• Wenhai Jin, Anna T. Brown, Anne M. Murphy
  Cardiac myofilaments: from proteome to pathophysiology
  Prot. Clin. Appl. 2008, 2, No. 06, 800-810.

• ---

• Chao Yuan, R. John Solaro
  Myofilament proteins: From cardiac disorders to proteomic changes
  Prot. Clin. Appl. 2008, 2, No. 06, 788-799.

• ---

• Lorna M. Cryan, Colm O'Brien
  Proteomics as a research tool in clinical and experimental ophthalmology
  Prot. Clin. Appl. 2008, 2, No. 05, 762-775.

• ---

• Rukhsana Sultana, D. Allan Butterfield
  Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress
  Prot. Clin. Appl. 2008, 2, No. 05, 685-696.

• ---

• Mohit Raja Jain, Wei-wen Ge, Stella Elkabes, Hong Li
  Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models
  Prot. Clin. Appl. 2008, 2, No. 05, 670-684.

• ---

• Svante Resjö, Karin Berger, Malin Fex, Ola Hansson
  Proteomic studies in animal models of diabetes
  Prot. Clin. Appl. 2008, 2, No. 05, 654-669.

• ---

• Nicolas Bousette, Anthony O. Gramolini, Thomas Kislinger
  Proteomics-based investigations of animal models of disease
  Prot. Clin. Appl. 2008, 2, No. 05, 638-653.

• ---

• Héctor F. Escobar-Morreale, María Insenser, Marta Cortón, José L. San Millán, Belén Peral
  Proteomics and genomics: A hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome
  Prot. Clin. Appl. 2008, 2, No. 03, 444-455.

• ---

• Martin H. Maurer, Daniel Haux, Andreas W. Unterberg, Oliver W. Sakowitz
  Proteomics of human cerebral microdialysate: From detection of biomarkers to clinical application
  Prot. Clin. Appl. 2008, 2, No. 03, 437-443.

• ---

• Stéphane Roche, Audrey Gabelle, Sylvain Lehmann
  Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers
  Prot. Clin. Appl. 2008, 2, No. 03, 428-436.

• ---

• Yutaka Yoshida, Masahito Miyamoto, Izumi Taguchi, Bo Xu, Ying Zhang, Eishin Yaoita, Hidehiko Fujinaka, Tadashi Yamamoto
  Human kidney glomerulus proteome and biomarker discovery of kidney diseases
  Prot. Clin. Appl. 2008, 2, No. 03, 420-427.

• ---

• Stijn Lambrecht, Kelly Tilleman, Dirk Elewaut, Dieter Deforce
  Proteomics in rheumatology: The beginning of a fairy tale?
  Prot. Clin. Appl. 2008, 2, No. 03, 411-419.

• ---

• Jason N. Cole, Anna Henningham, Christine M. Gillen, Vidiya Ramachandran, Mark J. Walker
  Human pathogenic streptococcal proteomics and vaccine development
  Prot. Clin. Appl. 2008, 2, No. 03, 387-410.

• ---

• Shraddha Kumari, Awanish Kumar, Mukesh Samant, Shyam Sundar, Neeloo Singh, Anuradha Dube
  Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis
  Prot. Clin. Appl. 2008, 2, No. 03, 372-386.

• ---

• Jens Rauch, Olivier Gires
  SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification
  Prot. Clin. Appl. 2008, 2, No. 03, 355-371.

• ---

• Chi Chun Wong, Ka Wing Cheng, Qing-Yu He, Feng Chen
  Unraveling the molecular targets of natural products: Insights from genomic and proteomic analyses
  Prot. Clin. Appl. 2008, 2, No. 03, 338-354.

• ---

• Masamichi Oh-Ishi, Yoshio Kodera, Sen-ichi Furudate, Tadakazu Maeda
  Disease proteomics of endocrine disorders revealed by two-dimensional gel electrophoresis and mass spectrometry
  Prot. Clin. Appl. 2008, 2, No. 03, 327-337.

• ---

• Michael Maris, Lut Overbergh, Chantal Mathieu
  Type 2 diabetes: Gaining insight into the disease process using proteomics
  Prot. Clin. Appl. 2008, 2, No. 03, 312-326.

• ---

• Hyun-Jung Kim, Hyun-Syuk Yoo, Chan-Wha Kim
  Proteomics in diabetic nephropathy
  Prot. Clin. Appl. 2008, 2, No. 03, 301-311.

• ---

• Yong-Doo Park, Daeui Park, Jong Bhak, Jun-Mo Yang
  Proteomic approaches to the analysis of atopic dermatitis and new insights from interactomics
  Prot. Clin. Appl. 2008, 2, No. 03, 290-300.

• ---

• Franck Brouillard, Janine Fritsch, Aleksander Edelman, Mario Ollero
  Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology
  Prot. Clin. Appl. 2008, 2, No. 02, 264-285.

• ---

• Richard Wilson, John F. Bateman
  Cartilage proteomics: Challenges, solutions and recent advances
  Prot. Clin. Appl. 2008, 2, No. 02, 251-263.

• ---

• Xiao-Li Wang, Alex Fu, Craig Spiro, Hon-Chi Lee
  Clinical application of proteomics approaches in vascular diseases
  Prot. Clin. Appl. 2008, 2, No. 02, 238-250.

• ---

• Roberto Scatena, Patrizia Bottoni, Bruno Giardina
  Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer
  Prot. Clin. Appl. 2008, 2, No. 02, 229-237.

• ---

• Katie Wing-kei Lam, Samuel Chun-lap Lo
  Discovery of diagnostic serum biomarkers of gastric cancer using proteomics
  Prot. Clin. Appl. 2008, 2, No. 02, 219-228.

• ---

• Kothandaraman Narasimhan, Zhao Changqing, Mahesh Choolani
  Ovarian cancer proteomics: Many technologies one goal
  Prot. Clin. Appl. 2008, 2, No. 02, 195-218.

• ---

• Metodi Metodiev, Louise Alldridge
  Phosphoproteomics: A possible route to novel biomarkers of breast cancer
  Prot. Clin. Appl. 2008, 2, No. 02, 181-194.

• ---

• Harold Tjalsma, Renée M. J. Schaeps, Dorine W. Swinkels
  Immunoproteomics: From biomarker discovery to diagnostic applications
  Prot. Clin. Appl. 2008, 2, No. 02, 167-180.

• ---

• Gary L. Nelsestuen, Stephen B. Harvey, Yan Zhang, Raj S. Kasthuri, Alan R. Sinaiko, E. Wesley Ely, Gordon R. Bernard, Monika Homoncik, Bernd Jilma
  Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkers
  Prot. Clin. Appl. 2008, 2, No. 02, 158-166.

• ---

• Stefano Barelli, Giorgia Canellini, Lynne Thadikkaran, David Crettaz, Manfredo Quadroni, Joël S. Rossier, Jean-Daniel Tissot, Niels Lion
  Oxidation of proteins: Basic principles and perspectives for blood proteomics
  Prot. Clin. Appl. 2008, 2, No. 02, 142-157.

• ---

• Mary K. Doherty, Robert J. Beynon, Phillip D. Whitfield
  Proteomics and naturally occurring animal diseases: Opportunities for animal and human medicine
  Prot. Clin. Appl. 2008, 2, No. 02, 135-141.

• ---

• Mones Abu-Asab, Mohamed Chaouchi, Hakima Amri
  Evolutionary medicine: A meaningful connection between omics, disease, and treatment
  Prot. Clin. Appl. 2008, 2, No. 02, 122-134.

• ---

EarlyView | 2010 | 2009 | 2008 | 2007

• Yue Ge, R. Julian Preston, Russell D. Owen
  Toxicoproteomics and its application to human health risk assessment
  Prot. Clin. Appl. 2007, 1, No. 12, 1613-1624.

• ---

• Ru Chen, Sheng Pan, Ruedi Aebersold, Teresa A. Brentnall
  Proteomics studies of pancreatic cancer
  Prot. Clin. Appl. 2007, 1, No. 12, 1582-1591.

• ---

• Susanne Beyer, Eilhard Mix, Raimund Hoffrogge, Katja Lünser, Uwe Völker, Arndt Rolfs
  Neuroproteomics in stem cell differentiation
  Prot. Clin. Appl. 2007, 1, No. 11, 1513-1523.

• ---

• Chia-Wei Chang, Sheng-Chih Peng, Wen-Yao Cheng, Szu-Heng Liu, Huei-Hsuan Cheng, San-Yuan Huang, Yen-Chung Chang
  Studying the protein–protein interactions in the postsynaptic density by means of immunoabsorption and chemical crosslinking
  Prot. Clin. Appl. 2007, 1, No. 11, 1499-1512.

• ---

• Joshua K. McBee, Li-Rong Yu, Yoshito Kinoshita, Takuma Uo, Richard P. Beyer, Timothy D. Veenstra, Richard S. Morrison
  Proteomic analysis of protein expression changes in a model of gliomagenesis
  Prot. Clin. Appl. 2007, 1, No. 11, 1485-1498.

• ---

• Ka Wan Li, August B. Smit
  Proteomics of brain synapses and molecular dissection of synaptic subdomains
  Prot. Clin. Appl. 2007, 1, No. 11, 1476-1484.

• ---

• Wei-Fei Diao, Wei-Qiang Chen, Harald Höger, Ki Shuk Shim, Arnold Pollak, Gert Lubec
  The hippocampal protein machinery varies over the estrous cycle
  Prot. Clin. Appl. 2007, 1, No. 11, 1462-1475.

• ---

• Eva-Maria Krämer-Albers, Niko Bretz, Stefan Tenzer, Christine Winterstein, Wiebke Möbius, Hendrik Berger, Klaus-Armin Nave, Hansjörg Schild, Jacqueline Trotter
  Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons?
  Prot. Clin. Appl. 2007, 1, No. 11, 1446-1461.

• ---

• Linda C. Miller, Wayne S. Sossin
  The significance of organellar proteomics for the nervous system
  Prot. Clin. Appl. 2007, 1, No. 11, 1436-1445.

• ---

• Mauro Fasano, Bruno Bergamasco, Leonardo Lopiano
  The proteomic approach in Parkinson's disease
  Prot. Clin. Appl. 2007, 1, No. 11, 1428-1435.

• ---

• Ming D. Li, Ju Wang
  Neuroproteomics and its applications in research on nicotine and other drugs of abuse
  Prot. Clin. Appl. 2007, 1, No. 11, 1406-1427.

• ---

• Stella Elkabes, Hong Li
  Proteomic strategies in multiple sclerosis and its animal models
  Prot. Clin. Appl. 2007, 1, No. 11, 1393-1405.

• ---

• Connie R. Jimenez, Marleen Koel-Simmelink, Thang V. Pham, Laura van der Voort, Charlotte E. Teunissen
  Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: Optimization of magnetic bead-based peptide capture and analysis of preanalytical variables
  Prot. Clin. Appl. 2007, 1, No. 11, 1385-1392.

• ---

• Yan Hu, Ava Hosseini, John S. K. Kauwe, Julia Gross, Nigel J. Cairns, Alison M. Goate, Anne M. Fagan, R. Reid Townsend, David M. Holtzman
  Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease
  Prot. Clin. Appl. 2007, 1, No. 11, 1373-1384.

• ---

• Günther K. H. Zupanc
  Proteomics of traumatic brain injury and regeneration
  Prot. Clin. Appl. 2007, 1, No. 11, 1362-1372.

• ---

• Keith Vosseller
  Proteomics of Alzheimer's disease: Unveiling protein dysregulation in complex neuronal systems
  Prot. Clin. Appl. 2007, 1, No. 11, 1351-1361.

• ---

• Jian-Ying Zhou, John Hanfelt, Junmin Peng
  Clinical proteomics in neurodegenerative diseases
  Prot. Clin. Appl. 2007, 1, No. 11, 1342-1350.

• ---

• Jun X. Wheeler, Caroline Vipond, Ian M. Feavers
  Exploring the proteome of meningococcal outer membrane vesicle vaccines
  Prot. Clin. Appl. 2007, 1, No. 09, 1198-1210.

• ---

• Jarlath E. Nally, Julian P. Whitelegge, James A. Carroll
  Proteomic strategies to elucidate pathogenic mechanisms of spirochetes
  Prot. Clin. Appl. 2007, 1, No. 09, 1185-1197.

• ---

• Philip Doran, Joan Gannon, Kathleen O'Connell, Kay Ohlendieck
  Proteomic profiling of animal models mimicking skeletal muscle disorders
  Prot. Clin. Appl. 2007, 1, No. 09, 1169-1184.

• ---

• Ruth Isserlin, Andrew Emili
  Nine steps to proteomic wisdom: A practical guide to using protein-protein interaction networks and molecular pathways as a framework for interpreting disease proteomic profiles
  Prot. Clin. Appl. 2007, 1, No. 09, 1156-1168.

• ---

• Rose P. Webster, Leslie Myatt
  Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies
  Prot. Clin. Appl. 2007, 1, No. 09, 1147-1155.

• ---

• David E. Sleat, Michel Jadot, Peter Lobel
  Lysosomal proteomics and disease
  Prot. Clin. Appl. 2007, 1, No. 09, 1134-1146.

• ---

• Judith A. P. Bons, Marja P. van Dieijen-Visser, Will K. W. H. Wodzig
  Clinical proteomics in chronic inflammatory diseases: A review
  Prot. Clin. Appl. 2007, 1, No. 09, 1123-1133.

• ---

• Fernando Vivanco, Sebastian Mas, Veronica M. Darde, Fernando De la Cuesta, Gloria Alvarez-Llamas, Maria G. Barderas
  Vascular proteomics
  Prot. Clin. Appl. 2007, 1, No. 09, 1102-1122.

• ---

• Marta Lomnytska, Serhiy Souchelnytskyi
  Markers of breast and gynecological malignancies: The clinical approach of proteomics-based studies
  Prot. Clin. Appl. 2007, 1, No. 09, 1090-1101.

• ---

• Raghothama Chaerkady, Akhilesh Pandey
  Quantitative proteomics for identification of cancer biomarkers
  Prot. Clin. Appl. 2007, 1, No. 09, 1080-1089.

• ---

• Mark Aspinall-O'Dea, Eithne Costello
  The pancreatic cancer proteome – recent advances and future promise
  Prot. Clin. Appl. 2007, 1, No. 09, 1066-1079.

• ---

• Magnus Hellström, Sara Jonmarker, Janne Lehtiö, Gert Auer, Lars Egevad
  Proteomics in clinical prostate research
  Prot. Clin. Appl. 2007, 1, No. 09, 1058-1065.

• ---

• Li-Rong Yu, Haleem J. Issaq, Timothy D. Veenstra
  Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets
  Prot. Clin. Appl. 2007, 1, No. 09, 1042-1057.

• ---

• Zhiyuan Hu, Leroy Hood, Qiang Tian
  Quantitative proteomic approaches for biomarker discovery
  Prot. Clin. Appl. 2007, 1, No. 09, 1036-1041.

• ---

• Frank Vitzthum, Gérard Siest, David M. Bunk, Tobias Preckel, Christian Wenz, Patric Hoerth, Peter Schulz-Knappe, Harald Tammen, Juergen Adamkiewicz, Giampaolo Merlini, N. Leigh Anderson
  Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable results
  Prot. Clin. Appl. 2007, 1, No. 09, 1016-1035.

• ---

• Sung-Min Ahn, Richard J. Simpson
  Body fluid proteomics: Prospects for biomarker discovery
  Prot. Clin. Appl. 2007, 1, No. 09, 1004-1015.

• ---

• José Bermúdez-Crespo, José Luis López
  A better understanding of molecular mechanisms underlying human disease
  Prot. Clin. Appl. 2007, 1, No. 09, 983-1003.

• ---

• Kaili Wu, Yanli Zhang
  Clinical application of tear proteomics: Present and future prospects
  Prot. Clin. Appl. 2007, 1, No. 09, 972-982.

• ---

• Michele Fiorini, Gianluigi Zanusso, Maria Donata Benedetti, Pier Giorgio Righetti, Salvatore Monaco
  Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis
  Prot. Clin. Appl. 2007, 1, No. 09, 963-971.

• ---

• Chun-Ming Huang
  In vivo secretome sampling technology for proteomics
  Prot. Clin. Appl. 2007, 1, No. 09, 953-962.

• ---

• Harvey B. Pollard, Meera Srivastava, Ofer Eidelman, Catherine Jozwik, Stephen W. Rothwell, Gregory P. Mueller, David M. Jacobowitz, Thomas Darling, William B. Guggino, Jerry Wright, Pamela L. Zeitlin, Cloud P. Paweletz
  Protein microarray platforms for clinical proteomics
  Prot. Clin. Appl. 2007, 1, No. 09, 934-952.

• ---

• Sophie Dahan, Eric Chevet, Jian-Feng Liu, Michel Dominguez
  Antibody-based Proteomics: From bench to bedside
  Prot. Clin. Appl. 2007, 1, No. 09, 922-933.

• ---

• Frédérique Lisacek, Christine Hoogland, Pierre Lescuyer, Denis F. Hochstrasser, Ron D. Appel
  Using bioinformatic resources in the proteomic analysis of biological fluids
  Prot. Clin. Appl. 2007, 1, No. 08, 900-915.

• ---

• David S. Gibson, Madeleine E. Rooney
  The human synovial fluid proteome: A key factor in the pathology of joint disease
  Prot. Clin. Appl. 2007, 1, No. 08, 889-899.

• ---

• Franz H. Grus, Stephanie C. Joachim, Norbert Pfeiffer
  Proteomics in ocular fluids
  Prot. Clin. Appl. 2007, 1, No. 08, 876-888.

• ---

• Mark W. Duncan, Heather S. Thompson
  Proteomics of semen and its constituents
  Prot. Clin. Appl. 2007, 1, No. 08, 861-875.

• ---

• Aggeliki Kolialexi, Ariadni Mavrou, George Th. Tsangaris
  Proteomic analysis of human reproductive fluids
  Prot. Clin. Appl. 2007, 1, No. 08, 853-860.

• ---

• Rachel L. Ruhlen, Edward R. Sauter
  Proteomics of nipple aspirate fluid, breast cyst fluid, milk, and colostrum
  Prot. Clin. Appl. 2007, 1, No. 08, 845-852.

• ---

• Yu-Chang Tyan, Pao-Chi Liao
  Proteomics analysis of serous fluids and effusions: Pleural, pericardial, and peritoneal
  Prot. Clin. Appl. 2007, 1, No. 08, 834-844.

• ---

• Sandra Tan, Cynthia R. M. Y. Liang, Khay Guan Yeoh, Jimmy So, Choy Leong Hew, Maxey C. M. Chung
  Gastrointestinal fluids proteomics
  Prot. Clin. Appl. 2007, 1, No. 08, 820-833.

• ---

• Jing Zhang
  Proteomics of human cerebrospinal fluid – the good, the bad, and the ugly
  Prot. Clin. Appl. 2007, 1, No. 08, 805-819.

• ---

• Harald Mischak, Bruce A. Julian, Jan Novak
  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine
  Prot. Clin. Appl. 2007, 1, No. 08, 792-804.

• ---

• Visith Thongboonkerd
  Recent progress in urinary proteomics
  Prot. Clin. Appl. 2007, 1, No. 08, 780-791.

• ---

• Gilbert S. Omenn
  THE HUPO Human Plasma Proteome Project
  Prot. Clin. Appl. 2007, 1, No. 08, 769-779.

• ---

• Richard R. Drake, Lisa Cazares, O. John Semmes
  Mining the low molecular weight proteome of blood
  Prot. Clin. Appl. 2007, 1, No. 08, 758-768.

• ---

• Zhaojing Meng, Timothy D. Veenstra
  Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers
  Prot. Clin. Appl. 2007, 1, No. 08, 747-757.

• ---

• Roisean E. Ferguson, Denis F. Hochstrasser, Rosamonde E. Banks
  Impact of preanalytical variables on the analysis of biological fluids in proteomic studies
  Prot. Clin. Appl. 2007, 1, No. 08, 739-746.

• ---

• David Perrett
  From ‘protein’ to the beginnings of clinical proteomics
  Prot. Clin. Appl. 2007, 1, No. 08, 720-738.

• ---

• Elzbieta Pastwa, Stella B. Somiari, Malgorzata Czyz, Richard Idem Somiari
  Proteomics in human cancer research
  Prot. Clin. Appl. 2007, 1, No. 01, 4-17.

• ---